Health TrialsbyHealthPanel

HILT vs ESWT in Supraspinatus Tendinitis

ConditionSupraspinatus Tendinitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorKafrelsheikh University

About this trial

This randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT) in patients with supraspinatus tendinitis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male and female participants aged between 18 and 60 years.

Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging.

Shoulder pain duration greater than 3 months.

Ability to understand and follow study instructions.

Disqualifiers

Full-thickness rotator cuff tear.

Previous shoulder surgery.

Pregnancy.

Neurological disorders affecting the upper limb.

Trial design

Design model

Parallel

Treatments tested in this trial

  • High-Intensity Laser Therapy

    Device

    High-Intensity Laser Therapy (HILT) is an advanced electrotherapy modality that uses high-power laser energy to penetrate deep musculoskeletal tissues and stimulate biological healing processes. The device emits laser wavelengths ranging between 808-1064 nm with high peak power output, allowing deeper tissue penetration compared to conventional low-level laser therapy. HILT provides analgesic, anti-inflammatory, and biostimulatory effects through increasing local blood circulation, enhancing cellular metabolism, stimulating collagen synthesis, and promoting tissue regeneration. The treatment is non-invasive, safe, and commonly used in musculoskeletal rehabilitation, particularly for tendinopathies and chronic pain conditions.

  • Extracorporeal Shock Wave Therapy

    Device

    Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive therapeutic modality that delivers high-energy acoustic waves to injured musculoskeletal tissues. The device generates focused or radial shock waves that stimulate tissue healing, neovascularization, pain reduction, and cellular repair mechanisms. ESWT is widely used in the management of tendinopathies, calcific disorders, and chronic musculoskeletal pain. Treatment parameters typically include energy flux density, frequency, number of impulses, and treatment sessions. The therapy is considered safe and effective, with minimal side effects

  • Conventional Physical Therapy

    Other intervention

    The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance. The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program. Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition

Treatment groups

48 Participants
are divided into 3 treatment groups
Group A: Group A: HILT + Conventional PTActive comparator 2 interventions
Group B: Group B: ESWT + Conventional PTActive comparator 2 interventions
Group C: Group C: Conventional Physical Therapy OnlyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain intensity measured using Visual Analogue Scale (VAS).

Pain intensity will be assessed using the Visual Analogue Scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain.

Time frame
At baseline and immediately after 4 weeks of intervention

Secondary outcomes

1

Shoulder Pain and Disability Measured by the Shoulder Pain and Disability Index (SPADI)

Shoulder pain and disability will be assessed using the Shoulder Pain and Disability Index (SPADI). The SPADI score ranges from 0 to 100, with higher scores indicating greater pain and disability.

Time frame
At baseline and immediately after 4 weeks of intervention
2

Upper Extremity Function Measured by the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)

Upper extremity function will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. DASH scores range from 0 to 100, with higher scores indicating greater disability.

Time frame
Time Frame: Baseline and immediately after 4 weeks of intervention.
3

Shoulder Range of Motion Measured Using a Digital Goniometer

Shoulder range of motion (flexion, abduction, and external rotation) will be measured in degrees using a digital goniometer. Higher values indicate greater shoulder mobility.

Time frame
Baseline and immediately after 4 weeks of intervention.
4

Quality of Life Measured by the Short Form-36 Health Survey (SF-36)

Quality of life will be assessed using the Short Form-36 Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better health-related quality of life.

Time frame
Baseline and immediately after 4 weeks of intervention.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kafrelsheikh University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: